Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
PLoS One. 2019 May 16;14(5):e0216568. doi: 10.1371/journal.pone.0216568. eCollection 2019.
Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are limited in Africa. We aimed to estimate the burden of fungal asthma among adults and children in Africa using a systematic review.
We first engaged the Institute for Health Metrics and Evaluation (IHME) to highlight the trend in morbidity and mortality attributed to asthma in Africa. We then searched PubMed, HINARI and Google Scholar for all studies of any design focusing on fungal asthma in any African country. Languages were restricted to English and French, but not year of publication. We estimated the weighted prevalence of allergic fungal infections among asthmatics with a 95% CI and pooled the results using a random effects model. This study is registered with PROSPERO, number CRD42019117319.
The IHME data showed that there has been a gradual increase in morbidity and mortality due to asthma in African adults with a prevalence of 4%. Our search retrieved 5233 citations. We retained 20 studies that met our selection criteria. These were from 13 African countries published between 1967 and 2018. There were eight cross-sectional studies and twelve review articles. The average asthma prevalence in Africa was 6% from these studies. The prevalence of fungal sensitisation was relatively high (3-52%) in the asthmatic population with an average of 28% and a pooled estimate of 23.3%, mostly due to Aspergillus species. Prevalence of Allergic bronchopulmonary apsergillosis was estimated at 1.6-21.2%. Diagnosis of fungal allergy was mostly made by skin prick tests. There was no data on the use of medication to manage fungal asthma. None of the studies evaluated the association between fungal allergy and asthma severity. Data were lacking in children.
There is a high prevalence of fungal sensitization among Africans with asthma. Fungal asthma is a significant problem in Africa but there remains a paucity of data on the epidemiology and associated complications. There is urgent need for national epidemiological studies to estimate the actual burden of fungal asthma in Africa.
哮喘是非洲被忽视的疾病之一,其患病率很高。过敏性真菌病已被报道会使哮喘的进展和治疗结果复杂化。然而,关于真菌性哮喘及其相关并发症的数据在非洲是有限的。我们旨在使用系统评价来估计非洲成人和儿童中真菌性哮喘的负担。
我们首先与健康指标与评估研究所(IHME)合作,突出显示归因于非洲哮喘的发病率和死亡率趋势。然后,我们在 PubMed、HINARI 和 Google Scholar 上搜索了所有在任何非洲国家研究真菌性哮喘的任何设计的研究。语言仅限于英语和法语,但不包括出版年份。我们使用随机效应模型估计过敏性真菌感染在哮喘患者中的加权患病率,并对结果进行汇总。本研究已在 PROSPERO 注册,编号 CRD42019117319。
IHME 数据显示,非洲成年人因哮喘导致的发病率和死亡率逐渐增加,患病率为 4%。我们的搜索检索到 5233 条引文。我们保留了 20 项符合我们选择标准的研究。这些研究来自 13 个非洲国家,发表于 1967 年至 2018 年之间。其中有 8 项是横断面研究,12 项是综述文章。这些研究中非洲的平均哮喘患病率为 6%。哮喘人群中真菌致敏的比例相对较高(3-52%),平均为 28%,汇总估计值为 23.3%,主要是由于曲霉菌属。过敏性支气管肺曲霉病的患病率估计为 1.6-21.2%。真菌过敏的诊断主要通过皮肤点刺试验进行。没有关于使用药物来治疗真菌性哮喘的数据。没有研究评估真菌过敏与哮喘严重程度之间的关系。在儿童中缺乏数据。
非洲哮喘患者中真菌致敏的比例很高。真菌性哮喘在非洲是一个严重的问题,但关于其流行病学和相关并发症的数据仍然缺乏。迫切需要进行国家流行病学研究,以估计真菌性哮喘在非洲的实际负担。